Abstract A101: Dose-related suppression of rat oral carcinogenesis by the EGF receptor-tyrosine kinase inhibitor, gefitinib
2010 ◽
Vol 27
(3)
◽
pp. 263-271
◽
2012 ◽
Vol 525
(1)
◽
pp. 16-24
◽
1998 ◽
Vol 41
(7)
◽
pp. 623-629
◽
2002 ◽
Vol 290
(1)
◽
pp. 349-358
◽
2007 ◽
Vol 104
(25)
◽
pp. 10607-10612
◽